NewStem Announces New Collaboration to Validate its Software Diagnostic Device for Two Oncology Indications and Two Therapies

By |2024-04-09T09:35:59+03:00December 14th, 2022|

NewStem Ltd., a bio-platform company, today announced a collaboration with the MSK Innovation Hub to further optimize and validate NewStem’s bioinformatics-based software as a medical device diagnostic platform.